FDA Adverse Event Malfunction Summary report: N

COBAS INTEGRA 800

MDR report key: 1746788 · Received August 8, 2007

Report

Report Number
1823260-2007-06905
Event Type
Malfunction
Date Received
August 8, 2007
Date of Event
July 22, 2007
Report Date
August 8, 2007
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JGS
PMA / PMN Number
K951595
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Description of Event or Problem · 1

ACCOUNT REPORTED HAVING ISSUES WITH SODIUM RECOVERY FOR PATIENT SAMPLES AND GAVE THE FOLLOWING PATIENT RESULTS AS EXAMPLES (SAMPLE# INITIAL/REPEAT ON ANOTHER ANALYZER MMOL/L): 109/138, 124/137. THE INCORRECT RESULTS WERE NOT REPORTED. THE FIELD SERVICE REP REPAIRED THE INSTRUMENT BY REPLACING THE REFERENCE ELECTRODE.

Description of Event or Problem · 2

ACCOUNT REPORTED HAVING ISSUES WITH SODIUM RECOVERY FOR PATIENT SAMPLES AND GAVE THE FOLLOWING PATIENT RESULTS AS EXAMPLES (SAMPLE# INITIAL/REPEAT ON ANOTHER ANALYZER MMOL/L): 109/133. THE INCORRECT RESULTS WERE NOT REPORTED. THE FIELD SERVICE REP REPAIRED THE INSTRUMENT BY REPLACING THE REFERENCE ELECTRODE.

Description of Event or Problem · 3

ACCOUNT REPORTED HAVING ISSUES WITH SODIUM RECOVERY FOR PATIENT SAMPLES AND GAVE THE FOLLOWING PATIENT RESULTS AS EXAMPLES (SAMPLE# INITIAL/REPEAT ON ANOTHER ANALYZER MMOL/L): 140/132. THE INCORRECT RESULTS WERE NOT REPORTED. THE FIELD SERVICE REP REPAIRED THE INSTRUMENT BY REPLACING THE REFERENCE ELECTRODE.

Description of Event or Problem · 4

ACCOUNT REPORTED HAVING ISSUES WITH SODIUM RECOVERY FOR PATIENT SAMPLES AND GAVE THE FOLLOWING PATIENT RESULTS AS EXAMPLES (SAMPLE# INITIAL/REPEAT ON ANOTHER ANALYZER MMOL/L): 159/134. THE INCORRECT RESULTS WERE NOT REPORTED. THE FIELD SERVICE REP REPAIRED THE INSTRUMENT BY REPLACING THE REFERENCE ELECTRODE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 COBAS INTEGRA 800 CLINICAL CHEMISTRY ANALYZER - JJE JGS ROCHE DIAGNOSTICS

Patients

Seq Age Sex Outcome Treatment
1 NA NP
2 23 YR NP
3 50 YR
4 25 YR